Evidence map›Paper›PMID 42726473›Full record

Trial reportDiabetes2026

The Effect of Obesity on the α-Cell Response to Hyperglycemia in the Presence of Amino Acids.

Sneha Mohan, Federica Boscolo, Hannah E Christie, Aoife M Egan, Kent R Bailey, Michael D Jensen, K Sree Nair, Chiara Dalla Man, Adrian Vella

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sneha MohanDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN.ORCID 0000-0002-4840-1802
Federica BoscoloDepartment of Information Engineering, University of Padua, Padua, Italy.ORCID 0009-0003-0545-7288
Hannah E ChristieDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN.ORCID 0000-0002-0606-6778
Aoife M EganDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN.ORCID 0000-0003-0379-9279
Kent R BaileyDivision of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN.
Michael D JensenDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN.ORCID 0000-0001-5589-8389
K Sree NairDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN.
Chiara Dalla ManDepartment of Information Engineering, University of Padua, Padua, Italy.ORCID 0000-0002-4908-0596
Adrian VellaDivision of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN.ORCID 0000-0001-6493-7837

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperglycemia in prediabetes is accompanied by increased amino acid (AA) concentrations and impaired suppression of glucagon secretion by glucose. It is unknown whether an abnormal response to AA contributes or hepatic steatosis exacerbates α-cell dysfunction. Therefore, lean participants and participants with obesity (with and without hepatic steatosis) were studied on two occasions in random order using a graded glucose infusion. Saline or an AA mixture was infused. The glucagon secretion rate (GSR) was derived from peripheral glucagon concentrations, and the change in glucose required to reduce GSR by 50% (G50) was calculated for each participant. AAs were measured during the experiment. On both occasions, experimental conditions produced a progressive rise in insulin secretion and an inverse exponential suppression of glucagon. G50 did not differ between groups in response to glucose alone. AA infusion did not change G50 in lean participants. G50 increased during AA infusion in participants with obesity with and without hepatic steatosis, leading us to report these participants as a single group. The relative change in AA concentrations across study days was generally similar between groups. We conclude that despite a normal response to glucose, obesity increases α-cell responses to AA in humans. ARTICLE HIGHLIGHTS: The aim of this study was to understand the pathogenesis of α-cell dysfunction in prediabetes. The primary hypothesis was that α-cell responsivity to glucose (reduction of the glucagon secretion rate by 50%) is impaired by amino acid (AA) infusion. A secondary hypothesis was that this abnormal response is exacerbated by hepatic steatosis. AA infusion impaired α-cell suppression in response to rising glucose in participants with obesity, but not in lean participants, despite a normal response to glucose alone. This abnormal response was unaffected by the presence or absence of hepatic steatosis. It seems likely that an abnormal α-cell response to AAs precedes an abnormal response to glucose alone.

Indexed as

Amino AcidsGlucagon-Secreting CellsHyperglycemiaObesityAdultBlood GlucoseFatty LiverFemaleGlucagonGlucoseHumansInsulinInsulin SecretionMaleMiddle AgedAmino AcidsBlood GlucoseGlucagonGlucoseInsulin

Identifiers

PMID42726473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.